-
, industrial and medical applications and new innovative biotech companies. The Laboratory for Genome Editing and System Genetics at CfM combines development of high-throughput genome editing tools with large
-
disease into specific subclasses. You will develop AI algorithms to train models that predict if individuals (from which we create circuits) are prone to develop disease and to identify conditions that have
-
scientist to study the human-specific genetic mechanisms of development and function of cortical neurons. Join us to undertake a highly interdisciplinary project focusing on a long-standing and fascinating
-
experiences and future goals a detailed CV including publication list contact information of 2-3 references The first review of applications will start immediately. A shortlist of applicants will be selected
-
Job description We’re looking for a postdoc with hands-on experience in genetically modifying marine phytoplankton—someone excited to learn how microbes naturally sequester carbon in the environment
-
, or National funding organizations). Starting Date: as soon as possible How to apply? Please complete the online application procedure and include a detailed CV, including a list of publications, a
-
excellent facilities and leading research groups in e.g. gastroenterology, oncology, immunology, microbiology & virology, clinical genetics/-omics, molecular biology and translational research. The Raes lab
-
(applications by email will not be considered). Please include a single pdf in your application that combines the following elements: • a detailed CV (including publication list if applicable) • a one-page
-
of cellular metabolism or physiology. Experience in genetic engineering of phytoplankton or mass spectrometry-based metabolomics is a plus. The postdoc will get training in high-throughput metabolomics and
-
brain connectivity, as defects in microglia have been recently linked to neurodevelopmental disorders. In addition, genetics of neurodegeneration place microglia as one of the central drivers of disease